22/04/2026
2 days to go for ๐จ๐๐ก ๐๐ก๐๐ข๐๐ข๐ฆ๐ โ ๐๐ข๐ฌ๐๐จ๐ฏ๐๐ซ๐ฒ ๐๐ฅ๐ฎ๐
We look forward to welcoming a curated group on 24th April at ๐๐ฎ๐๐
๐๐ผ๐ป ๐๐ผ๐๐๐ฒ for our ChaiTime โ Discovery Club. This invite-only session will bring together biotech leaders and decision-makers to present and discuss emerging modalities, evolving drug discovery strategies, and real-world insights across diverse therapeutic areas.
We have an exciting speaker line-up, covering a diverse range of topics shaping the future of drug discovery:
โ Sarah Skerratt, FRSC, PhD, Chief Research Officer, Isomorphic Labs
On AI-powered drug discovery: Using machine learning to predict molecular interactions
โ David Barrett, Head of Engineered Small Molecules & Oncology Research, Astellas Pharma
On Induced Proximity Modalities: The Future of Small Molecule Drug Discovery
โ Nigel Ramsden, PhD, VP, Drug Discovery, Cerevance
On Reflections on an Unintended Career in Covalent Inhibitors
โ Hitesh Sanganee, Venture Partner, Octopus Ventures
On AI : From Parrot to Problem Solver
If you would like to attend a future o2h ChaiTime session or be considered for upcoming sessions, feel free to reach out at [email protected]. We would be happy to invite you.